Robert P. Gray

2.0k total citations
26 papers, 1.3k citations indexed

About

Robert P. Gray is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Robert P. Gray has authored 26 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 8 papers in Cancer Research and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Robert P. Gray's work include Breast Cancer Treatment Studies (8 papers), Breast Lesions and Carcinomas (5 papers) and HER2/EGFR in Cancer Research (5 papers). Robert P. Gray is often cited by papers focused on Breast Cancer Treatment Studies (8 papers), Breast Lesions and Carcinomas (5 papers) and HER2/EGFR in Cancer Research (5 papers). Robert P. Gray collaborates with scholars based in United States, United Kingdom and Philippines. Robert P. Gray's co-authors include Nancy E. Davidson, Joseph A. Sparano, Frederick L. Baehner, Edward G. Mansour, Ahmad H. Shatila, Douglass C. Tormey, C. Kent Osborne, Geoffrey Falkson, Kennedy W. Gilchrist and M. Robert Cooper and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Robert P. Gray

24 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert P. Gray United States 15 859 718 352 197 181 26 1.3k
Mary Cianfrocca United States 14 533 0.6× 869 1.2× 279 0.8× 232 1.2× 239 1.3× 31 1.3k
Susanne Taucher Austria 23 954 1.1× 1.1k 1.5× 456 1.3× 316 1.6× 180 1.0× 45 1.7k
J. Collins Switzerland 16 806 0.9× 780 1.1× 322 0.9× 203 1.0× 184 1.0× 18 1.3k
J. N. Atkins United States 13 643 0.7× 754 1.1× 270 0.8× 151 0.8× 256 1.4× 24 1.2k
Pinuccia Valagussa Italy 10 1.0k 1.2× 1.2k 1.7× 439 1.2× 234 1.2× 256 1.4× 11 1.8k
Davide Disalvatore Italy 19 601 0.7× 684 1.0× 262 0.7× 266 1.4× 240 1.3× 29 1.3k
Hugh Bishop United Kingdom 6 643 0.7× 524 0.7× 259 0.7× 123 0.6× 187 1.0× 11 1.0k
Verena Hug United States 16 688 0.8× 767 1.1× 345 1.0× 234 1.2× 186 1.0× 44 1.4k
Ellen Schlichting Norway 21 676 0.8× 834 1.2× 224 0.6× 420 2.1× 213 1.2× 44 1.6k
G. Peruzzotti Italy 20 1.2k 1.4× 1.3k 1.8× 428 1.2× 460 2.3× 368 2.0× 44 2.1k

Countries citing papers authored by Robert P. Gray

Since Specialization
Citations

This map shows the geographic impact of Robert P. Gray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert P. Gray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert P. Gray more than expected).

Fields of papers citing papers by Robert P. Gray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert P. Gray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert P. Gray. The network helps show where Robert P. Gray may publish in the future.

Co-authorship network of co-authors of Robert P. Gray

This figure shows the co-authorship network connecting the top 25 collaborators of Robert P. Gray. A scholar is included among the top collaborators of Robert P. Gray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert P. Gray. Robert P. Gray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Gray, Robert P.. (2019). Art Therapy and Psychology: A Step-by-Step Guide for Practitioners. 1 indexed citations
3.
Gray, Robert P.. (2019). Art Therapy and Psychology.
4.
Solin, Lawrence J., Robert P. Gray, Lorie L. Hughes, et al.. (2015). Abstract P6-13-01: Local excision without radiation for ductal carcinoma in situ: 12-year results from the ECOG E5194 study. Cancer Research. 75(9_Supplement). P6–13. 1 indexed citations
5.
Solin, Lawrence J., Robert P. Gray, Frederick L. Baehner, et al.. (2013). A Multigene Expression Assay to Predict Local Recurrence Risk for Ductal Carcinoma In Situ of the Breast. JNCI Journal of the National Cancer Institute. 105(10). 701–710. 335 indexed citations
6.
Adams, Sylvia, Robert P. Gray, Sandra Demaria, et al.. (2013). Towards an immunoscore for triple negative breast cancer (TNBC): lymphocytic infiltrate predicts outcome. Journal for ImmunoTherapy of Cancer. 1(S1). 2 indexed citations
7.
8.
Sparano, Joseph A., Lori J. Goldstein, Nancy E. Davidson, George W. Sledge, & Robert P. Gray. (2012). TOP2A RNA expression and recurrence in estrogen receptor-positive breast cancer. Breast Cancer Research and Treatment. 134(2). 751–757. 14 indexed citations
9.
Zabel, T. Andrew, Jennifer Reesman, Ericka L. Wodka, et al.. (2010). Neuropsychological Features and Risk Factors in Children With Sturge-Weber Syndrome: Four Case Reports. The Clinical Neuropsychologist. 24(5). 841–859. 19 indexed citations
10.
DeMichele, Angela, Robert P. Gray, Jinbo Chen, et al.. (2009). Host Genetic Variants in the Interleukin-6 Promoter Predict Poor Outcome in Patients with Estrogen Receptor-Positive, Node-Positive Breast Cancer. Cancer Research. 69(10). 4184–4191. 45 indexed citations
11.
Sparano, Joseph A., Lori J. Goldstein, Barrett H. Childs, et al.. (2009). Relationship between Topoisomerase 2A RNA Expression and Recurrence after Adjuvant Chemotherapy for Breast Cancer. Clinical Cancer Research. 15(24). 7693–7700. 21 indexed citations
12.
Gray, Robert P., LJ Goldstein, BH Childs, et al.. (2009). GRB7-dependent pathways are potential therapeutic targets in triple-negative breast cancer.. Cancer Research. 69(2_Supplement). 25–25. 3 indexed citations
13.
Sparano, J. A., Robert P. Gray, Lori J. Goldstein, et al.. (2009). Gene Expression Profiling of Phenotypically-Defined Hormone-Receptor Positive Breast Cancer: Evidence for Increased Transcriptional Activity of the Insulin Growth Factor Receptor Pathway and Other Pathways.. Cancer Research. 69(24_Supplement). 5165–5165. 2 indexed citations
14.
Gray, Robert P., Barrett H. Childs, Tara Maddala, et al.. (2008). HER2 concordance between central laboratory immunohistochemistry and quantitative reverse transcription polymerase chain reaction in Intergroup Trial E2197. Journal of Clinical Oncology. 26(15_suppl). 22009–22009. 4 indexed citations
15.
Tallman, Martin S., Robert P. Gray, Nicholas J. Robert, et al.. (2003). Conventional Adjuvant Chemotherapy with or without High-Dose Chemotherapy and Autologous Stem-Cell Transplantation in High-Risk Breast Cancer. New England Journal of Medicine. 349(1). 17–26. 126 indexed citations
16.
Page, David L., Robert P. Gray, D. Craig Allred, et al.. (2001). Prediction of Node-Negative Breast Cancer Outcome by Histologic Grading and S-Phase Analysis by Flow Cytometry. American Journal of Clinical Oncology. 24(1). 10–18. 43 indexed citations
17.
Gray, Robert P., et al.. (1999). Empirically derived neuropsychological subgroups of school-age children. Archives of Clinical Neuropsychology. 14(1). 8–8. 1 indexed citations
18.
Tallman, Martin S., Robert P. Gray, John M. Bennett, et al.. (1995). Leukemogenic potential of adjuvant chemotherapy for early-stage breast cancer: the Eastern Cooperative Oncology Group experience.. Journal of Clinical Oncology. 13(7). 1557–1563. 81 indexed citations
19.
Gray, Robert P., et al.. (1990). Antrolith. Oral Surgery Oral Medicine Oral Pathology. 70(5). 682–683. 5 indexed citations
20.
Mansour, Edward G., Robert P. Gray, Ahmad H. Shatila, et al.. (1989). Efficacy of Adjuvant Chemotherapy in High-Risk Node-Negative Breast Cancer. New England Journal of Medicine. 320(8). 485–490. 275 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mary Cianfrocca Breakdown of academic impact, for papers by Susanne Taucher Breakdown of academic impact, for papers by J. Collins Breakdown of academic impact, for papers by J. N. Atkins Breakdown of academic impact, for papers by Pinuccia Valagussa Breakdown of academic impact, for papers by Davide Disalvatore Breakdown of academic impact, for papers by Hugh Bishop Breakdown of academic impact, for papers by Verena Hug Breakdown of academic impact, for papers by Ellen Schlichting Breakdown of academic impact, for papers by G. Peruzzotti
Rankless by CCL
2026